Earnings Call · Q4 FY2021·2022-02-28

Q4 21EPS -7.46%·Rev n/aQ3 21EPS +18.18%·Rev n/aQ2 21EPS -11.54%·Rev n/aQ1 21EPS -2.33%·Rev n/a⚠ consensus missing

FATE THERAPEUTICS INC FATE

Scott Wolchko — Chief Executive Officer

Ed Dulac — Executive or Senior Management

−0.4%1d on move date+1.1% vs SPY3d−4.3%5d−7.8%

Research tier

Behavioral profile computed for 2 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more FATE calls or request research access.

More FATE calls Browse calls Request research access